- 27 March
-
A meeting of the Committee on Entrepreneurship in Healthcare and Medical Industry of the Ural Chamber of Commerce and Industry was held in Ekaterinburg on March 18, 2025, chaired by Alexander Petrov. Participants of the event, including representatives of the Association of Medical Specialists for Risk Modification, the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, the Ural Biomedical Cluster and members of the Committee considered key challenges in maintaining the health of the able-bodied population, fighting against socially significant diseases and regulating prices for vital drugs.
- 05 December
-
The Russian pharmaceutical industry has gained significant stability in the recent years thanks to manufacturers such as Medsintez Plant. This is a modern full-cycle biotechnological enterprise that develops and manufactures pharmaceutical ingredients and drugs that meet international GMP and ISO standards.
- 27 September
-
On September 26, 2024, TASS hosted an expert discussion in the format of a federal teleconference Moscow-St. Petersburg-Ekaterinburg-Novosibirsk-Vologda-Anapa, dedicated to discussing the role, reasons and mechanisms for stimulating In Ekaterinburg, Alexander Petrov, the Chairman of the Board of Directors of Medsintez Plant LLC, told the participants about Triazavirin, an innovative domestic antiviral drug, as a success case of private investment in science.
- 07 September
-
60 leading Russian reproductologists visited the pharmaceutical company Medsintez Plant in Novouralsk on September 4, 2024. This event was timed to coincide with the celebration of the 3rd anniversary of the opening of the production workshop for biotechnological substances for the reproductive health of women, as well as the Annual International Conference «Reproductive Technologies Today and Tomorrow» in Ekaterinburg. Leading experts and conference speakers visited the production of the first Russian follitropin alpha for the treatment of human infertility, Primapur®.
- Home
- Cluster members
- Medin-N LLC
Medin-N LLC
Medin-N LLC is an actively developing enterprise, a recognized leader in the production of surgical needles and sutures in Russia. Since 1992, the company has been supplying surgical suture material to all regions of Russia and neighboring countries. Medin-N LLC offers more than two thousand combinations of absorbable and non-absorbable surgical sutures with atraumatic needles of various lengths and diameters: round, triangular, quadrangular, spatula-shaped, with conical sharpening and grooves.
The specialists of Medin- N LLC, together with the Postovsky Institute of Organic Synthesis, Ural branch of the Russian Academy of Sciences, have organized the only chemical production of absorbable polymer materials in Russia based on their own patented technologies. The company sells absorbable surgical products of its own manufacture: braided surgical sutures Sabfil and Sabfil Plus based on the polyglycolic and polylactic acids, absorbable monofilaments based on polydioxanone «Sabmon», absorbable monofilaments Soft Lift based on a copolymer of the lactic acid and ε- Caprolactone with notches for cosmetology, absorbable screws and pins for osteosynthesis. Polymer materials produced by Medin-N LLC are used by Leypunsky Institute of Physics and Power Engineering (IPPE) in the manufacture of absorbable strands for brachytherapy of prostate cancer. In close cooperation with health care institutions, the company is continuously developing import-substituting and innovative surgical products.
Medin-N LLC also produces a line of medical products: a set for infusion into the small veins of newborns, an endoloop for laparoscopic operations, needles for transvaginal follicle puncture, sets for vitrification of embryos/oocytes. The production of calcium phosphate materials for the replacement of bone tissue defects has been organized.
23A, Artinskaya St., Ekaterinburg
Tel.: (343) 212-58-82, 212-72-59
E-mail: sale@medin-n.ru
